Intra-vital imaging of an engineered mouse melanoma cell line, expressing GFP driven by a BRN2 promoter, has demonstrated motile, invasive cells leaving the site of the primary tumor had high expression of BRN2 while lacking pigmentation suggesting loss of MITF expression17. The gene discussed is MITF; the disease is melanoma.